Clinical Trial

Acceptance and Commitment Therapy (ACT) in Groups for Obsessive Compulsive Disorder: A Clinical Trial in Brazil

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2024 (before its estimated June 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if Acceptance and Commitment Therapy (ACT) + Exposure and Response Prevention (ERP) in Group is effective to Obsessive Compulsive Disorder (OCD) in adults. Researchers will compare intervention to control group to see if those who attend the group therapy have better results than control group. Participants will go through a 16-week group therapy based on a protocol designed by Michael Twohig (Twohig et al, 2018). * Participants will not have any medication adjustment during therapy * Participants will be assessed 3 times throughout the therapy, plus an assessment in a 6-month follow-up.
Trial Details
NCT Number NCT06548893
Lead Sponsor Universidade Federal do Paraná
Conditions Obsessive-Compulsive Disorder
Enrollment 24 participants
Start Date 2022-08-10
Primary Completion 2025-06-20 (estimated)
Study Completion 2026-06-20 (estimated)
Updated on ClinicalTrials.gov 2024-08-12